Valuation: Neuland Laboratories Limited

Market Cap 270B 2.87B 2.6B 2.4B 2.17B 4.09B 4.23B 28.88B 11.45B 144B 10.76B 10.54B 459B P/E 2027 *
61.9x
P/E 2028 * 46x
Enterprise Value 273B 2.9B 2.62B 2.43B 2.19B 4.13B 4.27B 29.15B 11.56B 146B 10.86B 10.63B 463B EV / Sales 2027 *
11.7x
EV / Sales 2028 * 9.49x
Free-Float
62.26%
Yield 2027 *
0.16%
Yield 2028 * 0.14%
1 day+0.79%
1 week+6.62%
Current month+7.01%
1 month+2.47%
3 months-6.33%
6 months+24.01%
Current year+38.78%
1 week 19,658.5
Extreme 19658.5
21,704.5
1 month 18,123.75
Extreme 18123.75
21,704.5
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 4,928
Extreme 4928
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 47 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%+6.62%+19.83%+294.28% 2.85B
+1.44%+6.85%+41.44%+136.13% 1,271B
+1.14%+3.83%+46.89%+94.28% 683B
+0.35%+1.49%+27.28%+113.25% 520B
-0.44%+3.32%+39.36%+70.94% 389B
+0.53%+0.69%+58.98%+44.18% 362B
-0.12%-0.04%+28.04%+59.86% 304B
+0.37%-0.43%+3.43%+38.57% 286B
-0.15%+1.31%+38.82%+74.90% 253B
+0.30%+0.88%+34.48%+124.70% 208B
Average +0.45%+2.14%+33.86%+105.11% 428B
Weighted average by Cap. +0.70%+2.68%+37.89%+96.96%

Financials

2027 *2028 *
Net sales 23.37B 248M 225M 208M 187M 353M 366M 2.5B 989M 12.48B 930M 910M 39.62B 28.6B 303M 275M 254M 229M 432M 448M 3.05B 1.21B 15.28B 1.14B 1.11B 48.5B
Net income 4.38B 46.5M 42.14M 38.97M 35.16M 66.27M 68.6M 468M 186M 2.34B 174M 171M 7.43B 5.9B 62.55M 56.69M 52.43M 47.31M 89.15M 92.29M 630M 250M 3.15B 235M 230M 10B
Net Debt 2.49B 26.41M 23.94M 22.14M 19.97M 37.64M 38.97M 266M 105M 1.33B 99.12M 97.02M 4.22B 1.08B 11.46M 10.39M 9.61M 8.67M 16.33M 16.91M 115M 45.76M 577M 43.01M 42.1M 1.83B
Projected Income Statement - Annual - Neuland Laboratories Limited
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
13/11/26 INR 21,081.70 +0.79% 2,274
12/11/26 INR 20,916.60 +3.52% 2,402
11/11/26 INR 20,204.85 -0.58% 4,357
09/11/26 INR 20,323.05 +2.25% 3,066
08/11/26 INR 19,876.80 +0.91% 651
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Neuland Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21,081.70INR
Average target price
24,675.00INR
Spread / Average Target
+17.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Neuland Laboratories Limited
  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock